In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm characterized by ane···【more】
Release date:2024-11-27Recommended:485
Selinexor's high-profile therapeutic drug has once again ignited a flame of ···【more】
Release date:2024-11-27Recommended:491
Dose adjustment regimen for selinexor in the treatment of diffuse large B-cell l···【more】
Release date:2024-11-26Recommended:529
How many generic drugs are there in Laos Lucius Selineso?This study aims to dete···【more】
Release date:2024-11-26Recommended:465
The price of generic capmatinib in LaosCapmatinib has been approved for the trea···【more】
Release date:2024-11-25Recommended:499
There are several generic versions of the Laos Lucius version of capmatinibMET d···【more】
Release date:2024-11-25Recommended:466
Gilteritinib, as a FLT3 inhibitor, has demonstrated significant clinical activit···【more】
Release date:2024-11-22Recommended:408
This study aims to investigate the safety and efficacy of the combination of gil···【more】
Release date:2024-11-22Recommended:489
What are the side effects of gilitinib?The FLT3 inhibitor Gilteritinib (Xospata)···【more】
Release date:2024-11-21Recommended:405
Gireltinib is primarily effective in acute myeloid leukemia (AML), particularly ···【more】
Release date:2024-11-21Recommended:399
Patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase···【more】
Release date:2024-11-20Recommended:447
Lorlatinib is a highly potent third-generation ALK and ROS1 tyrosine kinase inhi···【more】
Release date:2024-11-20Recommended:517